05th week of 2014 patent applcation highlights part 52 |
Patent application number | Title | Published |
20140031387 | LFA-1 INHIBITOR AND METHODS OF PREPARATION AND POLYMORPH THEREOF - Methods of preparation and purification of a compound of Formula I, intermediates thereof, a polymorph thereof, and related compounds are disclosed. Formulations and uses thereof in the treatment of LFA-1 mediated diseases are also disclosed. | 2014-01-30 |
20140031388 | AKT INACTIVATION BY TOCOPHERYL DERIVATIVES - Anticancer compounds according to formula I are described herein. | 2014-01-30 |
20140031389 | SCREENING METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASES - The present invention relates to screening methods and pharmaceutical compositions for the treatment of inflammatory bowel disease. More particularly, the present invention relates to a method for screening a plurality of test substances useful for the prevention or treatment of an inflammatory bowel disease comprising the steps consisting of (a) testing each of the test substances for its ability to restore the integrated stress response and (b) and positively selecting the test substances capable of restoring said integrated stress response. A further aspect of the invention relates to an agent capable of restoring the integrated stress response (ISR) for use in the treatment of an inflammatory bowel disease. | 2014-01-30 |
20140031390 | PITAVASTATIN-CONTAINING PREPARATION AND METHOD FOR PRODUCING SAME - The present invention provides a pitavastatin-containing preparation containing pitavastatin or a pharmacologically acceptable salt thereof and at least one kind of a basic additive selected from the group consisting of basic magnesium compounds and basic calcium compounds, and an aqueous solution or an aqueous dispersion of the pitavastatin-containing preparation having a pH of more than 8 and 10 or less; and a method for producing a pitavastatin-containing preparation, including blending at least one kind of a basic additive selected from the group consisting of basic magnesium compounds and basic calcium compounds with pitavastatin or a pharmacologically acceptable salt thereof, to make an aqueous solution or an aqueous dispersion of the pitavastatin-containing preparation have a pH of more than 8 and 10 or less. | 2014-01-30 |
20140031391 | Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use - The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders. | 2014-01-30 |
20140031392 | A NON-RETINOID RBP4 ANTAGONIST FOR TREATMENT OF AGE-RELATED MACULAR DEGENERATION AND STARGARDT DISEASE - A method for treating bisretinoid-mediated macular degeneration in a mammal afflicted therewith comprising administering to the mammal an effective amount of a compound having the structure: | 2014-01-30 |
20140031393 | PYRROLE COMPOUNDS - The present invention relates to a compound represented by the formula: | 2014-01-30 |
20140031394 | CYCLIC SULFONIUM SALT, PROCESS FOR PRODUCTION OF SAME, AND alpha-GLUCOSIDASE INHIBITOR COMPRISING SAME - Provided is a novel cyclic sulfonium salt compound which is useful for the prevention or treatment of diabetes and the like. The present invention relates to a novel cyclic sulfonium salt compound represented by general formula (I) or (II), an isomer or solvate of the compound, or a pharmaceutically acceptable salt of the compound or the isomer or solvate. The present invention also relates to an α-glucosidase inhibitor, a pharmaceutical composition for preventing or treating diabetes, and an anti-diabetes food, each of which comprises the compound represented by general formula (I) or (II) and the like. | 2014-01-30 |
20140031395 | Positive Allosteric Modulators of the Alpha 7 Nicotinic Acetylcholine Receptor and uses Thereof - The present invention relates to compounds useful in the positive modulation of the alpha 7 nicotinic acetylcholine receptor (α7nAChR). The invention also relates to the use of these compounds in the treatment or prevention of a broad range of diseases in which the positive modulation of α7nAChR is advantageous, including neurodegenerative and neuropsychiatric diseases and also inflammatory diseases. | 2014-01-30 |
20140031396 | Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient - Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP binder. | 2014-01-30 |
20140031397 | Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient - Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder. | 2014-01-30 |
20140031398 | TRPM8 RECEPTOR ANTAGONISTS - Compounds acting as selective antagonists of Transient Receptor Potential cation channel subfamily M member 8 (hereinafter referred to as TRPM8), having formula: | 2014-01-30 |
20140031399 | SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS - The present invention provides a compound of formula (I): | 2014-01-30 |
20140031400 | MACROCYCLIC COMPOUNDS AND METHODS OF TREATMENT - The instant invention describes macrocyclic compounds having therapeutic activity, and methods of treating disorders such as cancer, tumors and cell proliferation related disorders, or affect cell differentiation, dedifferentiation or transdifferentiation. | 2014-01-30 |
20140031401 | Modified Release Formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and Methods of Using the Same - Modified release pharmaceutical compositions (controlled release, sustained release, and/or extended release) of the R-(+) enantiomer of pramipexole (RPPX) and methods of using such compositions for the treatment of neurodegenerative diseases, or those related to mitochondrial dysfunction or increased oxidative stress are disclosed. | 2014-01-30 |
20140031402 | Process for the Syntheses of Triazoles - The present invention relates to processes for the preparation of triazoles. These compounds are useful as anti-infective, anti-proliferative, anti-inflammatory, and prokinetic agents. | 2014-01-30 |
20140031403 | Solid Forms of Curcumin - The present invention provides forms of curcumin and the pharmaceutical compositions thereof. The forms of curcumin disclosed herein are curcumin polymorph Form III, curcumin-2-aminobenzimidazole co-crystal, and curcumin-L-lysine co-crystal. Further, the invention provides methods inhibiting cancer cells and HSV-1 using these curcumin novel solid forms. | 2014-01-30 |
20140031404 | CANNABINOID RECEPTOR ANTAGONISTS/INVERSE AGONISTS USEFUL FOR TREATING DISEASE CONDITIONS, INCLUDING METABOLIC DISORDERS AND CANCERS - The present invention provides novel, diastereomeric pyrazolines that are useful as cannabinoid receptor blockers and pharmaceutical compositions thereof and methods of using the same for treating obesity, diabetes, inflammatory disorders, cardiometabolic disorders, hepatic disorders, and/or cancers. | 2014-01-30 |
20140031405 | NOVEL CARBOXAMIDE MICROBIOCIDES - Compounds of formula (I) wherein R | 2014-01-30 |
20140031406 | PYRAZOLE COMPOUND - The present invention relates to a novel serotonin reuptake inhibitor which also exhibits 5-HT | 2014-01-30 |
20140031407 | (5S,8S)-3-(4'-CHLOR-3'-FLUOR-4-METHLYBIPHENYL-3-YL)-4-HYDROXY-8-METHOXY-1-- AZASPIRO[4.5]DEC-3-EN-2-ONE (COMPOUND A) FOR TREATMENT - The invention relates to (5s,8s)-3-(4′-chloro-3′-fluoro-4-methylbiphenyl-3-yl)-4-hydroxy-8-methoxy-1-azaspiro[4.5]dec-3-en-2-one for therapeutic purposes, to pharmaceutical compositions and to their use in therapy, in particular for the prophylaxis and therapy of tumour disorders. | 2014-01-30 |
20140031408 | Biodegradable Intravitreal Tyrosine Kinase Implants - Biocompatible intraocular implants include a tyrosine kinase inhibitor and a biodegradable polymer that is effective to facilitate release of the tyrosine kinase inhibitor into the vitreous of an eye for an extended period of time. The therapeutic agents of the implants may be associated with a biodegradable polymer matrix, such as a matrix that is substantially free of a polyvinyl alcohol. The implants can be placed in an eye to treat or reduce the occurrence of one or more ocular conditions. | 2014-01-30 |
20140031409 | METHODS FOR TREATING ANDROGEN RECEPTOR DEPENDENT DISORDERS INCLUDING CANCERS - The invention provides the combination use of antisense oligomers targeting androgen receptor mRNA and androgen receptor binding inhibitors that reduce androgen receptor activity for the treatment of androgen receptor related medical disorders, such as cancers, particularly prostate cancers and breast cancers. | 2014-01-30 |
20140031410 | COMPOSITIONS AND METHODS FOR MODULATING ANGIOGENESIS - The invention generally features compositions and methods that are useful for modulating angiogenesis. | 2014-01-30 |
20140031411 | GPNMB/OSTEOACTIVIN AS A BIOMARKER AND DRUG TARGET IN CARDIAC DISEASES - The present invention relates to the gene Gpnmb and its use as a genetic marker in the incidence of cardiovascular conditions and cardiac diseases, such as complications derived from myocardial infarction. Gpnmb provides a valuable tool both for diagnostic as well as therapeutic approaches, in order to treat or prevent cardiovascular conditions and cardiac diseases, in particular complications derived from myocardial infarction. | 2014-01-30 |
20140031412 | METHOD OF TREATMENT - The present disclosure teaches the treatment of a blood pathology, such as a blood pathology associated with impaired hemoglobin synthesis including the treatment of β-thalassemia or a related hemoglobinopathy. An RNA molecule such as a short interfering RNA or a hairpin RNA which targets an mRNA species encoding α-globin is administered to a subject to reduce the amount of α-globin produced to non-zero levels and ameliorate the effects of an α- and β-globin chain imbalance. | 2014-01-30 |
20140031413 | METHOD AND COMPOSITIONS COMPRISING SMALL RNA AGONIST AND ANTAGONISTS TO MODULATE INFLAMMATION - The disclosure provides methods and compositions for modulating inflammation. | 2014-01-30 |
20140031414 | SIRNA TARGETING VEGFA AND METHODS FOR TREATMENT IN VIVO - Vascular endothelial growth factor A (VEGFA) is a chemical signal produced by cells that stimulates the growth of new blood vessels, and overexpression of VEGFA can lead to undesirable physiological conditions. Through the identification of new siRNA and modifications that improve the silencing ability of these siRNA in vivo, therapeutic compositions and methods have been invented to address the problems associated with this overexpression. | 2014-01-30 |
20140031415 | METHODS AND COMPOSITIONS INVOLVING MIRNA AND MIRNA INHIBITOR MOLECULES - The present invention concerns methods and compositions for introducing miRNA activity or function into cells using synthetic nucleic acid molecules. Moreover, the present invention concerns methods and compositions for identifying miRNAs with specific cellular functions that are relevant to therapeutic, diagnostic, and prognostic applications wherein synthetic miRNAs and/or miRNA inhibitors are used in library screening assays. | 2014-01-30 |
20140031416 | Multifunctional Aptamer-Nucleic Acid Nanostructures for Tumor-Targeted Killing - The present invention provides compositions comprising a ligand-nucleic acid nanostructure that promote tumor cell-specific killing and methods of using the compositions. Specially, the invention provides aptamer-nucleic acid nanostructures for treating tumors in a mammal. The methods of making the compositions are also provided. | 2014-01-30 |
20140031417 | SKELETAL MUSCLE-SPECIFIC ENHANCER - The invention relates to a novel skeletal muscle-specific p57 regulatory element. This element is useful to drive and enhance the specific skeletal muscle expression of therapeutic genes. It is therefore provided nucleic acids and vectors comprising said enhancer element, as well as pharmaceutical compositions comprising the vectors, and uses thereof. | 2014-01-30 |
20140031418 | Regimens and Compositions for AAV-Mediated Passive Immunization of Airborne Pathogens - A prophylactic regimen for passively preventing infection with a pathogen which has a typical route of infection through the nasopharynx region of a subject, e.g., an airborne virus typically transmitted through coughing or sneezing. The method involves specifically targeting a subject's nasopharynx with a viral vector comprising an AAV capsid and carrying a nucleic acid sequence encoding an anti-viral neutralizing antibody construct operably linked to expression control sequences, in order to provide for high levels of expression of the anti-viral neutralizing antibody construct in the nasal airway cells. Optionally, the neutralizing antibody construct is expressed under a promoter which is regulated or induced by a small molecule which is delivered separately from the viral vector. In one embodiment, the method permits transfection of a subject's nasopharynx even where the subject has circulating neutralizing antibodies against the AAV capsid. | 2014-01-30 |
20140031419 | Na/K-ATPase Ligands, Ouabain Antagonists, Assays and Uses Thereof - The present disclosure relates to methods of inhibiting the ATPase activity of Na/K-ATPase without stimulating the receptor function, methods of blocking Na/K-ATPase interaction with Src, methods of inhibiting cell growth, and methods of abolishing ouabain-provoked signaling transduction in the heart of a subject, which includes providing an effective amount of at least one hydroxyl xanthone derivative. | 2014-01-30 |
20140031420 | COMPOSITION AND METHOD FOR TREATING DIABETES AND METABOLIC DISORDERS - A composition and method for treating diabetes and metabolic disorders, and for achieving weight loss in a subject comprising a combination of naturally occurring compounds is provided. | 2014-01-30 |
20140031421 | NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS - The present invention provides synthetic processes for preparing racemic and/or optically pure epicatechin, epigallocatechin and related polyphenols as such or as their variously functionalized derivatives. A principle objective of the disclosure is to provide a new and useful method of synthesis to obtain polyphenols in isomerically pure and/or racemic forms. | 2014-01-30 |
20140031422 | Compositions and Methods for Treating Bruises - A composition for the treatment of bruising is disclosed. The composition can include an antioxidant, one or more citrus flavanoids, as active agents along with a pharmaceutically acceptable excipient or filler. The compositions are nutriceutical formulations having the capacity to reduce the number of bruises that occur over time and that reduce the healing time of bruises. The compositions are preferably in tablet form for oral consumption one or more times per day. A method of reducing bruising is also disclosed in which a patient in need of a treatment for bruising or at risk of developing bruises is identified. The composition can then be administered orally to the patient. | 2014-01-30 |
20140031423 | AMINO ACID SALTS OF PROSTAGLANDINS - The present invention is directed to novel amino acid prostaglandin salts and methods of making and using them. | 2014-01-30 |
20140031424 | REDUCED DRYING CARRIER FORMULATION - According to the present invention there is provided a carrier formulation adapted to operatively support a preservative or preservative mixture within a material for treating wood, said carrier formulation comprising water and one or more water-miscible, water-soluble or water-emulsifiable compounds wherein said carrier formulation provides for preservative penetration and substantial preservative retention within the treated wood; and wherein the treated wood requires relatively little post-treatment drying. The carrier formulation provides for substantially complete or envelope penetration of the preservative within the treated wood. | 2014-01-30 |
20140031425 | DISINFECTING AND ANTIMICROBIAL COMPOSITIONS - Broad spectrum disinfecting and microbicidal compositions of biodegradable and environmentally friendly compositions containing esters formed from fatty organic alcohols and fatty carboxylic acids. These compositions display activities against the most resistant microbial forms including bacterial spores. The preparations can be used in health care, food processing, personal care and other industries where the use of harsh oxidizing chemicals is undesirable. | 2014-01-30 |
20140031426 | SN-1(3) MONOACYLGLYCERIDES AND LIPID ABSORPTION - The present invention relates generally to the field of lipids and in particular aims at improving lipid absorption, for example under conditions of lipid maldigestion or malabsorption. One embodiment of the present invention relates to a composition comprising sn-1(3) monoacylglycerols, wherein the sn-1 or sn-3 position is occupied by an acyl group such as a fatty acid and the sn-2 position remains unoccupied. The fatty acid may be one with anti-inflammatory properties. | 2014-01-30 |
20140031427 | COMBINATIONS OF ADAPALENE AND BENZOYL PEROXIDE FOR TREATING ACNE LESIONS - Adapalene or a pharmaceutically acceptable salt thereof formulated into a pharmaceutical composition is useful for reducing the number of acne lesions, via daily topical application, in combination or in association with benzoyl peroxide (BPO); such treatment may be via administration of a pharmaceutical composition combining adapalene and BPO or by a concomitant application of two pharmaceutical compositions, one containing adapalene and the other containing BPO. | 2014-01-30 |
20140031428 | METHOD FOR TREATING SCHIZOPHRENIA - The present invention provides a novel fatty acid derivative. The present invention also provides a method for treating schizophrenia in a mammalian subject, which comprises administering to the subject in need thereof an effective amount of a fatty acid derivative. | 2014-01-30 |
20140031429 | COMPOUNDS FOR TREATING PROLIFERATIVE DISORDERS - Disclosed are compounds and methods of using compounds of the invention for treating a subject with a proliferative disorder, such as cancer, and methods for treating disorders responsive to Hsp70 induction and/or natural killer induction. Also, disclosed are pharmaceutical compositions comprising compounds of the invention and a pharmaceutically acceptable carrier. | 2014-01-30 |
20140031430 | NOVEL ANTIFUNGAL COMPOSITION - There is provided a pharmaceutical composition for the treatment of fungal infection of the nail comprising a anti-fungal allylamine compound present in an amount of about 10%, an organic acid or an ester thereof, a diol and a sequestering agent where the pharmacological composition is essentially water-free | 2014-01-30 |
20140031431 | PEST-IMPERVIOUS PACKAGING MATERIAL AND PEST-CONTROL COMPOSITION - A composition-of-matter comprising a substance usable in producing packaging material and at least one compound selected from the group consisting of ar-turmerone, a sesquiterpene alcohol and a turmeric oleoresin solid residue. | 2014-01-30 |
20140031432 | TREATMENT OF MITOCHONDRIAL DISEASES WITH VITAMIN K - Methods of treating, preventing or suppressing symptoms associated with mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), dominant optic atrophy (DOA); mitochondrial myopathy, encephalopathy, lactacidosis, stroke (MELAS), Leigh syndrome or Kearns-Sayre Syndrome (KSS) with vitamin K are disclosed. | 2014-01-30 |
20140031433 | FORMULATIONS OF TOCOTRIENOL QUINONES FOR THE TREATMENT OF OPHTHALMIC DISEASES - A formulation, comprising an ophthalmically effective amount of one or more tocotrienol quinones, particularly of alpha-tocotrienol quinone is disclosed. Use of a formulation comprising one or more tocotrienol quinones for the prevention, reduction, amelioration or treatment of ophthalmic disorders that are associated with a neurodegenerative or trauma disorder is also discussed. A method of treating or controlling the ocular symptoms associated with neurodegenerative diseases or trauma with a formulation comprising one or more tocotrienol quinones is also discussed. A method of treating or controlling the ocular symptoms associated with mitochondrial myopathies with a formulation comprising one or more tocotrienol quinones is also discussed. | 2014-01-30 |
20140031434 | Use of Patchouli Alcohol in Preparation of Drug Against Helicobacter Pylori - The present invention relates to a use of patchouli alcohol in the preparation of a drug against | 2014-01-30 |
20140031435 | PROPOFOL COMPOSITIONS AND METHODS FOR REDUCING PAIN ASSOCIATED WITH PROPOFOL INJECTION - The present invention pertains to pharmaceutical formulations containing propofol, methods for making such formulations, and methods for administering propofol at a pH above about 6.5, wherein the pain normally associated with propofol administration is reduced. | 2014-01-30 |
20140031436 | Polylactide Hydrosol and Articles Made Therefrom - A polylactide hydrosol polymer formulations suitable for thin film articles and methods of making the thin film articles are provided. The formulations and methods can be use to make articles such as gloves, condoms, catheters and the like using dip forming, and various casting processes. | 2014-01-30 |
20140031437 | OIL-IN-WATER EMULSIONS - The invention provides an oil-in-water emulsion suitable for cosmetic or personal care use, the emulsion comprising: a) a aqueous continuous phase; b) a dispersed oil phase, and c) optionally, a nonionic emulsifier; in which the aqueous continuous phase is structured by a dispersed modified cellulose biopolymer, wherein the modification consists of the cellulose having its C6 primary alcohols oxidised to carboxyl moieties (acid/COOH—) on 10 to 70% of the glucose units and substantially all the remainder of the C6 positions occupied by unmodified primary alcohols; and in which the emulsion comprises less than 0.2 wt % anionic surfactant (by total weight anionic surfactant based on the total weight of the emulsion). | 2014-01-30 |
20140031438 | METHOD AND SYSTEM FOR PRODUCING METHANOL FROM INERT-RICH SYNGAS - A method for producing methanol from inert-rich syngas includes installing a catalytic pre-reactor is upstream of the single or mufti-stage synthesis loop, a first part of the syngas being converted to methanol in the catalytic pre-reactor. Furthermore, an inert gas separation stage, for example a pressure swing adsorption system or a membrane system, is connected downstream of the synthesis loop, whereby a hydrogen-enriched syngas stream can be returned to the synthesis loop. In the processing of methane-rich syngas, the inert gas separation stage may also comprise an autothermal reformer in which methane is converted to carbon oxides and hydrogen, which are also returned into the synthesis loop. | 2014-01-30 |
20140031439 | FILLED NANOPOROUS POLYMER MEMBRANE COMPOSITES FOR PROTECTIVE CLOTHING AND METHODS FOR MAKING THEM - A new class of membranes for use in protective clothing. More specifically, the present invention relates to a polymer-polymer membrane with an ionic polymer located within the nanopores of a porous polymer host membrane. A method for making the polymer-polymer membranes involves filling porous polymers with ionic polymers. The porous polymers may be fabricated by a template synthesis which involves sorption. The ionic polymers may be filled in the nanopores of the porous polymer by plasma-induced graft copolymerization of the ionic polymer with the porous polymeric host membrane. | 2014-01-30 |
20140031440 | METHOD FOR THE PREPARATION OF MODIFIED POLY(ALKYLENE TEREPHTHALATE) EMPLOYING IN SITU TITANIUM-CONTAINING CATALYST - A process of preparing a modified polyalkylene terephthalate by melt polycondensation comprising reacting an alkylene diol and polyethylene terephthalate, wherein polymerization occurs in the presence of a catalyst complex formed by reaction of tetra(alkyl) titanate and a compound selected from phosphorus-containing compounds, nitrogen-containing compounds, boron-containing compounds, and combinations thereof. | 2014-01-30 |
20140031441 | Process for the Preparation of Modified Poly(Alkylene Terephthalate) Employing an In-Situ Titanium-Containing Catalyst - Disclosed is an improved process for preparing a modified polyalkylene terephthalate by melt polycondensation followed optionally by solid state condensation comprising reacting an alkylene diol and polyethylene terephthalate, wherein polymerization occurs in the presence of a catalyst complex formed by reaction of tetra(alkyl) titanate and a compound selected from phosphorus-containing compounds, nitrogen-containing compounds, boron-containing compounds, and combinations thereof. | 2014-01-30 |
20140031442 | BLOWING AGENT COMPOSITIONS OF HYDROCHLOROFLUOROOLEFINS - The present invention relates to foam products made with blowing agent compositions comprising at least one hydrochlorofluoroolefin (HCFO) used in the preparation of Namable thermoplastic compositions. The HCFOs of the present invention include, but are not limited to, 1-chloro-3,3,3-trifluoropropene (HCFO-1233zd), particularly the trans-isomer, 2-chloro-3,3,3-trifluoropropene (HCFO-1233xf), dichloro-fluorinated propenes, and mixtures thereof. The blowing agent compositions of the present invention are used with coblowing agents including carbon dioxide, atmospheric gases, hydrofluorocarbons (HFC), hydrofluoroolefins (HFO), alkanes, hydrofluoroethers (HFE), and mixtures thereof. Preferred HFCs used as coblowing agents in the present invention include, but are not limited too, 1,1,1,2-tetrafluoroethane (HFC-134 | 2014-01-30 |
20140031443 | PROCESS FOR PRODUCING POLYETHER POLYOL, PROCESS FOR PRODUCING FLEXIBLE POLYURETHANE FOAM, AND SHEET - To suppress deterioration of mechanical properties of a foam, by using a polyol system solution stored.
| 2014-01-30 |
20140031444 | POLYURETHANE FOAMS COMPRISING PHOSPHORUS COMPOUNDS - The present invention relates to polyurethanes obtained by mixing to give a reaction mixture of (a) polyisocyanate, (b) polymeric compounds having groups reactive toward isocyanates, (c) catalysts comprising incorporable amine catalysts, (d) phosphoric esters, polyphosphates, phosphonic esters, and/or phosphorous esters, and optionally (e) blowing agents, (f) chain extenders and/or crosslinking agents, and (h) auxiliaries and/or additives, and completing the reaction of the reaction mixture to give the polyurethane. The invention further relates to a process for producing these polyurethanes and to their use in automobile interiors. | 2014-01-30 |
20140031445 | HEAT INSULATING MATERIAL - A method of manufacturing a resin foam includes dissolving a blowing agent into a mixture of a resin C and a resin D having a difference of solubility with respect to the blowing agent in an amount of more than 0% and less than 5%; subjecting the mixture to heat-melting for extrusion; and evaporating the blowing agent such that the resin foam has a porosity (X) of not less than 80%, a cell (L) with a cell diameter of not less than 1 μm and not more than 1000 μm, and a cell (S) with a cell diameter of not less than 0.01 μm and less than 1 μm, in which two peaks are present in cell diameter distribution, one peak thereof being present in not less than 10 μm and not more than 500 μm and the other peak being present in not less than 0.01 μm and less than 1 μm. | 2014-01-30 |
20140031446 | UV HARDENING GLASS PRINTING INK AND UV HARDENING GLASS PRINTING LACQUER AND METHOD FOR PRINTING A GLASS SUBSTRATE - A glass printing ink and a glass printing lacquer comprising at least one pigment, at least one photoinitiator, at least two resins and radicial photoinitiators. One resin is an epoxy resin having an average molecular weight based on bisphenol A, diluted in a UV hardening monomer. The other resin is a resin which contains free functional amino, hydroxy, epoxy, acid, acid anhydride and/or acrylate groups. Also, the use of the glass printing ink and glass printing lacquer when printing a glass substrate and to a method for printing a glass substrate. | 2014-01-30 |
20140031447 | SILICONE HYDROGELS HAVING A STRUCTURE FORMED VIA CONTROLLED REACTION KINETICS - The present invention relates to a process comprising the steps of reacting a reactive mixture comprising at least one silicone-containing component, at least one hydrophilic component, and at least one diluent to form an ophthalmic device having an advancing contact angle of less than about 80°; and contacting the ophthalmic device with an aqueous extraction solution at an elevated extraction temperature, wherein said at least one diluent has a boiling point at least about 10° higher than said extraction temperature. | 2014-01-30 |
20140031448 | TWO DIMENSIONAL POLYMERS AND METHODS OF MAKING SAME - The present invention relates to two dimensional polymers and methods of making the same. Irradiation of polycyclic, three bladed monomers, such as polyaromatic, three bladed monomers or an antrip monomer, derivatives or analogues thereof, with ultraviolet radiation provides the two dimensional polymers, which may be used in membrane applications. | 2014-01-30 |
20140031449 | SILICONE HYDROGELS FORMED FROM ZERO DILUENT REACTIVE MIXTURES - The present invention relates to silicone hydrogels having a desirable balance of properties which can be formed without diluents. The silicone hydrogels are formed from reactive mixtures comprising at least one hydroxyl substituted, monofunctional polydialkylsiloxane monomer having between 2 and 120 dialkylsiloxane repeating units, at least one slow reacting hydrophilic monomer and at least one hydroxyl containing hydrophilic monomer. | 2014-01-30 |
20140031450 | BONE TREATMENT SYSTEMS AND METHODS - The present disclosure relates to bone cement formulations that have an extended working time for use in vertebroplasty procedures and other osteoplasty procedures together with cement injectors that include energy delivery systems for on-demand control of cement viscosity and flow parameters. The bone cement formulations may include a liquid component having at least one monomer and a non-liquid component including polymer particles and benzoyl peroxide (BPO). The non-liquid component may be further configured to allow controlled exposure of the BPO to the liquid monomer so as to enable control of the viscosity of the bone cement composition. | 2014-01-30 |
20140031451 | PASTE-LIKE BONE CEMENT - A paste contains at least one monomer for radical polymerisation, at least one polymer that is soluble in said at least one monomer for radical polymerisation, and at least one filling agent that is poorly soluble or insoluble in said at least one monomer for radical polymerisation. The filling agent is a particulate inorganic calcium salt comprising the following properties: at least 90% by weight of the particulate inorganic calcium salt have a particle size of less than 63 μm, as determined by means of sieve analysis; and the solubility in water of the particulate inorganic calcium salt at 20° C. is less than 8.5 g per litre. A kit and the paste is usable for mechanical fixation of articular endoprostheses, for covering skull defects, for filling bone cavities, for femuroplasty, for vertebroplasty, for kyphoplasty, for the manufacture of spacers or for the production of carrier materials for local antibiotics therapy, as well as a form body. | 2014-01-30 |
20140031452 | SILICIC ACID CONDENSATES HAVING A LOW DEGREE OF CROSS-LINKING IN A POLYMER MATRIX - A material or biomaterial comprising silicic acid condensates having a low degree of cross-linking, and methods for its production are subject-matter of the invention. A method for the production of silicic acid structures having a low degree of cross-linking is disclosed, wherein a sol is produced, wherein further condensation is prevented when specific cross-linking of the silicic acid is reached, wherein, preferably, structures having a size of 0.5-1000 nm are produced, e.g. polyhedral structures or aggregates of the same. Further condensation can be prevented by means of mixing with a polymer. In one embodiment, this comprises nano-structured, silicon dioxide (SiO | 2014-01-30 |
20140031453 | POLYCARBONATE BLOCK COPOLYMERS - The disclosure pertains to amphiphilic block copolymers comprising an aliphatic polycarbonate chain coupled to a hydrophilic polymer. Such amphiphilic polymers may have the formula A-L-B, where A- is a polycarbonate or polyethercarbonate chain having from about 3 to about 500 repeating units, L is a linker moiety and —B is a hydrophilic oligomer having from about 4 to about 200 repeating units. Provided copolymers are useful as surfactants capable of emulsifying aqueous solutions and supercritical carbon dioxide. Provided copolymers also have utility as additives for use in enhanced oil recovery methods. | 2014-01-30 |
20140031454 | PROCESS FOR THE PREPARATION OF POLY(ALKYLENE TEREPHTHALATE) EMPLOYING AN IN-SITU TITANIUM-CONTAINING CATALYST AND COMPOSITIONS DERIVED THEREFROM - Disclosed is a process for the manufacture of a polyalkylene terephthalate such as polybutylene terephthalate. In particular, the process comprises employing a titanium-containing catalyst formed by the reaction product of tetraalkyl titanate and a complexing agent comprising a phosphorous, nitrogen or boron atom. The process is used to prepare polyalkylene terephthalates characterized by improved hydrostability, as well as compositions derived therefrom. | 2014-01-30 |
20140031455 | METHOD FOR PRODUCING A COMPOUND BASED ON PSEUDOLAMINAR SILICATES AND THE USE THEREOF AS A FILLER FOR POLYMERIC MATERIALS - The present invention relates to a method for producing a compound that comprises a pseudolaminar silicate of natural origin, which is at least one clay of the paligorskite-sepiolite group, characterized in that said method comprises the following steps: defibrillating the microfibre bundles of the at least one clay in water; dispersing the defibrillated clay in an organic or inorganic liquid solvent until a stable gel is formed; adding to the dispersion at least one clay-surface-modifying agent; removing the solvent from the dispersion by means of a solid-liquid separation process and/or drying process; and deagglomerating the final compound until a powdered product is obtained. A further object of the present invention is the compound that can be obtained using said method, as well as the use of the compound as an additive or filler in composite polymeric materials in order to enhance the properties thereof, the composite polymeric material likewise being encompassed within the present invention. | 2014-01-30 |
20140031456 | PROCESS FOR THE PREPARATION OF MODIFIED POLY(ALKYLENE TEREPHTHALATE) EMPLOYING AN IN-SITU TITANIUM-CONTAINING CATALYST AND COMPOSITIONS DERIVED THEREFROM - Disclosed is a process for the manufacture of a modified polyalkylene terephthalate such as modified polybutylene terephthalate. In particular, the process comprises employing a titanium-containing catalyst formed by the reaction product of tetraalkyl titanate and a complexing agent comprising a phosphorous, nitrogen or boron atom. The process is used to prepared modified polyalkylene terephthalates characterized by improved hydrostability, as well as compositions and compositions derived therefrom. | 2014-01-30 |
20140031457 | PROCESS FOR THE PREPARATION OF POLY(ALKYLENE TEREPHTHALATE) EMPLOYING IN SITU TITANIUM-CONTAINING CATALYST AND COMPOSITIONS DERIVED THEREFROM - Disclosed is a process for the manufacture of a polyalkylene terephthalate such as polybutylene terephthalate. In particular, the process comprises employing a titanium-containing catalyst formed by the reaction product of tctraalkyl titanate and a complexing agent comprising a phosphorous, nitrogen or boron atom. The process is used to prepare polyalkylene terephthalates characterized by improved hydrostability, as well as compositions derived therefrom. | 2014-01-30 |
20140031458 | METHOD FOR PRODUCING AND MONITORING AN OBJECT AT LEAST PARTIALLY MADE OF PLASTIC, AND COMPONENT - During the production of reinforced and non-reinforced components ( | 2014-01-30 |
20140031459 | MODIFIED PROPYLENE RESIN - It is an object of the present invention to provide a modified propylene resin containing very small amounts of low-crystalline and low-molecular-weight components. The present invention relates to a modified propylene resin characterized by satisfying the following requirements (1) to (4). (1) The melting point (Tm) measured with a differential scanning calorimeter (DSC) is 140° C. or higher. (2) The amount of grafts of ethylenic unsaturated bond-containing monomer after hot xylene washing is 0.1 to 5 percent by weight. (3) The amount of components soluble in o-dichlorobenzene at 70° C. is 1.5 percent by weight or less. (4) The intrinsic viscosity [η] is 0.1 to 4 dl/g. | 2014-01-30 |
20140031460 | FLAME-RETARDANT RESIN COMPOSITION, METHOD FOR PRODUCING SAME, AND MOLDED ARTICLE THEREOF - A flame retardant resin composition contains: a thermoplastic resin containing a cellulosic resin; and a flame retardant, wherein the flame retardant is composed of: first metal hydroxide particles having a particle size of 100 nm to 1000 nm and having particle surfaces modified with an epoxy silane coupling agent, at 40% by weight to 60% by weight of the whole flame retardant; and second metal hydroxide particles having a particle size of 10 nm to 50 nm and having particle surfaces modified with an amino silane coupling agent, at 60% by weight to 40% by weight of the whole flame retardant. This flame retardant resin composition containing a cellulosic resin is provided with excellent flame retardancy, mechanical properties, and moldability. | 2014-01-30 |
20140031461 | FLUORORUBBER COMPOSITION - A fluororubber composition comprising 100 parts by weight of a peroxide-crosslinkable tetrafluoroethylene-vinylidene fluoride-hexafluoropropene ternary copolymer rubber having a fluorine content of 64 wt. % or more, (A) 5 to 90 parts by weight of carbon black having a specific surface area of 5 to 20 m | 2014-01-30 |
20140031462 | CONTROLLED RHEOLOGY FORMULATIONS CONTAINING HIGH MELT STRENGTH POLYPROPYLENE FOR EXTRUSION COATING - A process of extruding a blend of an irradiated first propylene polymer and a non-irradiated second propylene polymer, where the first propylene polymer comprises a non-phenolic stabilizer. The irradiation of the first propylene polymer extrudate is conducted in a reduced oxygen environment, and the irradiated first propylene polymer and the non-irradiated second propylene polymer are blended at a temperature below their respective melting points. The blend has a viscosity retention of 20 to 35%. | 2014-01-30 |
20140031463 | COMPOSITION OF MICROCAPSULES WITH A SILICA SHELL AND A METHOD FOR THEIR PREPARATION - A process for the preparation of a microcapsule composition, wherein the shell of the microcapsules is essentially made of silica and the core comprises at least one lipophilic component, comprising the steps of:
| 2014-01-30 |
20140031464 | CHLOROSULFONATED POLYETHYLENE LATEX - A chlorosulfonated polyethylene latex, which is safe for living bodies and the environment and can be used as a latex component in a resorcin-formalin-latex adhesive, contains an aqueous dispersion medium, chlorosulfonated polyethylene, and an emulsifying agent of a polyoxyalkylene alkyl ether sulfate of formula (I) below and a fatty acid salt. The latex is excellent in standing stability and mechanical stability. In formula (I), R | 2014-01-30 |
20140031465 | Curable Organosiloxane Block Copolymer Emulsions - The present disclosure provides aqueous silicone emulsions of a “resin-linear” organosiloxane block copolymers. The present disclosure further provides a process for making these emulsions by forming a mixture of an organosiloxane block copolymer, admixing a sufficient amount of water to the mixture from to form an emulsion, and optionally further shear mixing the emulsion. The present invention further relates to the cured and/or coating compositions prepared from the present emulsions. | 2014-01-30 |
20140031466 | PROCESS FOR THE PREPARATION OF MODIFIED POLY(ALKYLENE TEREPHTHALATE) EMPLOYING AN IN-SITU TITANIUM-CONTAINING CATALYST AND COMPOSITIONS DERIVED THEREFROM - Disclosed is a process for the manufacture of a modified polyalkylene terephthalate such as modified polybutylene terephthalate. In particular, the process comprises employing a titanium-containing catalyst formed by the reaction product of tetraalkyl titanate and a complexing agent comprising a phosphorous, nitrogen or boron atom. The process is used to prepare modified polyalkylene terephthalates characterized by improved hydrostability, as well as compositions derived therefrom. | 2014-01-30 |
20140031467 | ANTIDRIFT COMPOSITION - A solid, water-soluble fast-dissolving antidrift composition includes a urea-based complex-forming component (i) complexed with an antidrift component (ii), the antidrift composition optionally further including an adjuvant component (iii). | 2014-01-30 |
20140031468 | NANOCLAY HYBRIDS AND ELASTOMERIC COMPOSITES CONTAINING SAME - Disclosed herein is a methodology for producing modified nanoclays which, when added to an elastomer, provide elastomeric nanocomposites with improved ageing, rheological and mechanical properties, and which can be devoid of, or containing low amount of, a filler such as carbon black. The modified nanoclays are made of a nanoclay, such as organomodified nanoclay, modified so as to be in association with an amine-containing antioxidant and optionally also with a silyl-containing compound, such as mercaptosiloxane. Also disclosed herein are processes of preparing the modified nanoclays, elastomeric composites containing same and articles containing the elastomeric composites. | 2014-01-30 |
20140031469 | AQUEOUS FLUOROPOLYMER DISPERSION - The present invention provides an aqueous fluoropolymer dispersion that shows favorable dispersion stability and is less likely to have a pH decrease even after storage for a long period of time. The present invention provides an aqueous fluoropolymer dispersion including: a fluoropolymer; a fluorine free surfactant; at least one organic electrolyte selected from the group consisting of hydroxy monocarboxylic acids, hydroxy dicarboxylic acids, tricarboxylic acids, and amino acids; and a fluorine-containing anionic surfactant containing not more than 7 carbon atoms. | 2014-01-30 |
20140031470 | DIAMINO ALCOHOL AND STRONG BASE NEUTRALIZERS FOR LOW VOC COATING COMPOSITIONS - A coating composition comprising a binder, a carrier, a pigment, cations selected from the group consisting of alkali metal cations, ammonium cations, and mixtures thereof, and at least one diamino alcohol selected from the group consisting of compounds of Formula I and compounds of Formula II. The present invention also provides a method for reducing the volatile organic compound (VOC) content of a coating composition having a binder, a carrier, and a pigment, which comprises including in the coating composition the aforesaid A) cations and B) at least one diamino alcohol. | 2014-01-30 |
20140031471 | Stabilization Of Polymers That Contain A Hydrolyzable Functionality - A process for treating a polymer having a hydrolyzable functionality, the method comprising: (i.) providing a polymer having hydrolyzable functionality; and (ii.) introducing a stabilizing agent to the polymer, where the stabilizing agent is defined by the formula (I) where ÷ is a hydrolyzable group that forms an acidic species upon hydrolysis, where R | 2014-01-30 |
20140031472 | Systems and Methods for Polystyrene Foam Recycling Using Branched Dibasic Esters - Methods and systems for reducing the volume of polystyrene foam wherein a foam reducing agent is applied to the foam, the foam reducing agent in some embodiments comprising a branched dibasic ester blend. | 2014-01-30 |
20140031473 | METHOD FOR PRODUCING POLYACRYLIC ACID (SALT)-BASED WATER ABSORBENT RESIN POWDER - From a viewpoint of reduction in an out of spec product after surface crosslinking, particularly, when an alkylene carbonate compound is used as a surface crosslinking agent, influence by an air temperature is great, and it is necessary to reduce ethylene glycol which is produced as a byproduct, and there is provided a process for producing a polyacrylic acid (salt)-based water absorbent resin powder, comprising
| 2014-01-30 |
20140031474 | ELECTRIC CABLE - To provide an electric cable that can satisfy flame retardancy and battery fluid resistance in the CHFUS region provided in ISO 6722 and also satisfy low-temperature resistance, wear resistance, and peelability by using a halogen-containing flame retardant. An electric cable in which a coat layer is formed of a non-crosslinked resin composition that includes (A) 40 to 84 parts by mass of a polypropylene homopolymer, (B) 1 to 10 parts by mass of a polypropylene-based modified resin, (C) 10 to 30 parts by mass of a polyolefin-based copolymer, and (D) 5 to 20 parts by mass of an olefin-based elastomer and further includes 1 to 45 parts by mass of a metal hydroxide and 10 to 80 parts by mass of a halogen-containing flame retardant based on 100 parts by mass of the resins (A), (B), (C), and (D) in total. | 2014-01-30 |
20140031475 | SEAL RING - Provided is a seal ring manufactured from a mixture containing a soft resin including at least one of a thermoplastic elastomer and a dynamic crosslinked resin, and a hard resin including a thermoplastic resin. With this seal ring, the adhesion to the inner peripheral surface of a housing can be maintained in a no-load state where a hydraulic pressure is not generated even after use as a one-piece type for an extended period of time and oil leakage can be effectively prevented. The mixture constituting the seal ring preferably has a compression permanent deformation of 95% or lower after immersion in an automatic transmission fluid at 150° C. for 100 hours. | 2014-01-30 |
20140031476 | THERMOPLASTIC COMPOSITION FOR USE IN HIGH IMPACT APPLICATIONS - A thermoplastic composition comprising from about 50 to about 99 by weight percent of a nylon 6,6 resin, from about 1 to about 50 by weight percent of a polymer performance modifier and about from 0.01 to about 25 by weight percent of a silicone based additive, wherein the silicone based additive comprises an ultrahigh molecular weight siloxane polymer that is unfunctionalized and non-reactive with the polyamide resin, wherein the thermoplastic composition has an impact strength value which is greater than the combination of the polyamide resin and the polymer performance modifier or the combination of the polyamide resin and the silicone based additive and wherein the thermoplastic composition has an ultimate tensile strength that is at least 80% that of the combination of the polyamide resin and the polymer performance modifier. | 2014-01-30 |
20140031477 | PROCESS FOR FORMING AN ARAMID COPOLYMER - The invention concerns processes for forming polymer crumb comprising residues of 2-(4-amino phenyl)-5 (6) amino phenyl benzimidazole (DAPBI), paraphenylene diamine (PPD), and terephthaloyl dichloride (TCl), comprising the steps of: i) forming a slurry of b mole percent DAPBI in a solvent system comprising organic solvent and c weight percent of an inorganic salt, wherein the inorganic salt is present in an amount of at least 5 weight present of the organic solvent; ii) contacting the slurry with a less than stoichiometric amount of terephthaloyl chloride to form an prepolymer solution; and iii) contacting the prepolymer solution with y mole percent of PPD and additional TCL to form a polymer solution; wherein the total amount of TCL added in steps ii) and iii) is a stoichiometric amount based on the total amount of DAPBI and PPD added in steps i) and iii); the DAPBI and PPD are added in an amount sufficient for providing a polymer solution having a weight percent solids of 12 percent or greater on a polymer basis; and wherein the sum of y+b is 100 and the product of b×c is 225 or greater. | 2014-01-30 |
20140031478 | Electrostatic Dissipative Polycarbonate Compositions - The present invention relates to electrostatic dissipative polycarbonate compositions that are prepared by combining an aromatic polycarbonate polymer with a thermoplastic polyurethane based inherently dissipative polymer and a compatibilizer component that comprises a second thermoplastic polyurethane. This second thermoplastic polyurethane is a reaction product of (a) at least one polyol intermediate, (b) at least one diisocyanate, and (c) at least one chain extender, wherein (a), the polyol intermediate comprises a polycaprolactone polyol, a polycarbonate polyol, or combinations thereof. | 2014-01-30 |
20140031479 | USE OF ALUMINA TRIHYDRATE IN COMPOSITES - A composite comprising a flame retardant, such as ATH and an expandable graphite is disclosed. | 2014-01-30 |
20140031480 | POLYPROPYLENE HOMOPOLYMERS WITH HIGH HEAT DEFLECTION TEMPERATURE, HIGH STIFFNESS AND FLOWABILITY - The invention relates to a polypropylene composition showing a high melt flow rate and simultaneously high stiffness and a process for the production thereof. The invention further relates to a material comprising the inventive polypropylene. | 2014-01-30 |
20140031481 | Polyamide compositions and article manufactured therefrom - Polyamide composition very well suited for the manufacture of LED devices comprising: (a) at least a polyamide comprising recurring units derived from at least one C6 and/or at least one C10 diamine and from at least one dicarboxylic acid of the formula HO—C(═O)—R—C(═O)—OH wherein R is a cycloaliphatic moiety; (b) at least a reinforcing filler, and (c) at least a white pigment selected from a group consisting of TiO | 2014-01-30 |
20140031482 | Rubber Composition For Use In Tire Side Walls And Pneumatic Tire Using The Same - A rubber composition for use in tire side walls contains from 30 to 40 parts by mass of carbon black having a nitrogen specific surface area of from 20 to 35 m | 2014-01-30 |
20140031483 | COATINGS REPAIRABLE BY INTRODUCTION OF ENERGY - The present invention relates to coating compositions repairable by introduction of energy and comprising defined fatty acid esters, to coatings obtained therewith and repairable by introduction of energy, to methods of producing them, and to their use. | 2014-01-30 |
20140031484 | BLOCK POLYISOCYANATE COMPOUND - It is an object of the invention to provide a block polyisocyanate compound with excellent storage stability. The block polyisocyanate compound of the invention has the following construction. A block polyisocyanate compound having at least one block isocyanate group selected from the group consisting of a block isocyanate group represented by formula (I), block isocyanate group represented by formula (II) and block isocyanate group represented by formula (III), and a hydrophilic group. | 2014-01-30 |
20140031485 | FILTRATION MEMBRANE WITH COVALENTLY GRAFTED FOULING-RESISTANT POLYMER - A method of photo-grafting onto a separation membrane a copolymer includes at least one of: | 2014-01-30 |
20140031486 | WATERBORNE COATINGS - An aqueous coating composition comprising:
| 2014-01-30 |